Clinical Trials Browser

INDUSTRY × Expanded_access × Crizotinib × Clear all

NCT02473497 2024-06-26

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

No longer available

Neoplasms

NCT02824094 2017-07-21

Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC

No longer available

Carcinoma, Non-Small-Cell Lung, Neoplasms